WHO's low-cost strategies to prevent noncommunicable diseases Media release 14 January 2013 Pages: 1 - 1
NICE recommendations for treating TB in hard-to-reach groups Media release 14 January 2013 Pages: 2 - 2
Healthcare cut-back debates absurd when overprescribing rife Media release 14 January 2013 Pages: 3 - 3
Bisphosphonates: advanced age no barrier to cost effectiveness Clinical study 14 January 2013 Pages: 4 - 4
Lifestyle modification could head off diabetes and save costs Clinical study 14 January 2013 Pages: 4 - 4
Bosentan PAH patient registry confirm its worth in Australia Clinical study 14 January 2013 Pages: 6 - 6
Genetic testing before therapy may be worth it in severe MDD . . . Clinical study 14 January 2013 Pages: 7 - 7
Oseltamivir: cost effective for uncomplicated seasonal influenza? Clinical study 14 January 2013 Pages: 9 - 9
Prolonged valganciclovir best for CMV in high-risk patients Clinical study 14 January 2013 Pages: 9 - 9
Pneumococcal vax: which is best for Australian infants? Clinical study 14 January 2013 Pages: 10 - 10
Zelrix and Levadex would be drugs of choice if priced better Media release 14 January 2013 Pages: 11 - 11